CAS number: 282526-98-1
Therapeutic segment: Metabolic disorders (Anti-obesity/ lipid absorption inhibitors)
API class/drug class: Gastrointestinal and Pancreatic Lipase Inhibitor
Chemical name: 2-hexadecoxy-6-methyl-3,1-benzoxazin-4-one
Molecular formula: C25H39NO3
Molecular weight: 401.6 g/mol
Form: White to off-white crystalline powder
Packaging type: Double LDPE bags packed in HDPE drums or equivalent pharma-grade, moisture-protective packaging
Storage conditions: Store in a refrigerator (2°C to 8°C). Keep the container tightly closed and protect from light and moisture.
Specification: As per USP/PhEur/IP (as applicable) or in-house specifications
Application area: Treatment of obesity and management of metabolic disorders (type-2 diabetes) by inhibiting fat absorption in the intestine.
GMP: Y
DMF: T/P
USFDA: Y

EDQM: Y

▼

Product Description:

Cetilistat is an API belonging to the class of gastrointestinal and pancreatic lipase inhibitors, indicated for the treatment of obesity and associated metabolic disorders. Supplied as a white to off-white crystalline powder, it is an active pharmaceutical ingredient that acts locally in the gastrointestinal tract to inhibit dietary fat absorption, supporting weight management and glycaemic control in patients with type-2 diabetes. The product is supplied in double LDPE bags packed in HDPE drums or equivalent pharma-grade, moisture- and light-protective packaging.

As a leading distribution partner, Molkem Chemicals ensures reliable supply of products aligned with industry quality standards and regulatory expectations. Each product is delivered as per agreed specifications, supported by standard documentation including COA, SDS, and TDS. If required, our technical team can provide additional stability data and regulatory assistance.

Related Product

Edoxaban Tosylate

Eberconazole Mononitrate

Ebastine

Doxycycline Monohydrate